Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma
- Noriko Kimura⇑,
- Ryoichi Takayanagi1,
- Nae Takizawa2,
- Eiji Itagaki3,
- Takayuki Katabami4,
- Narihiko Kakoi5,
- Hiromi Rakugi6,
- Yukihiro Ikeda7,
- Akiyo Tanabe8,
- Takeshi Nigawara9,
- Sadayoshi Ito10,
- Itaru Kimura11,
- Mitsuhide Naruse12,
- The Phaeochromocytoma Study Group in Japan†
- Pathology Division, Department of Clinical Research, National Hospital Organization, Hakodate Hospital, Postal cord 041-8512, 18-16 Kawahara,
Hakodate, Hokkaido, Japan
1Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
2Department of Urology and Andrology, Kansai Medical University, Osaka, Japan
3Third Department of Internal Medicine (Diabetes Endocrine and Metabolism), School of Medicine, Kyorin University, Tokyo, Japan
4Department of Medicine, Metabolism and Endocrinology, School of Medicine, St Marianna University, Kawasaki, Japan
5Department of Urology, Miyagi Cancer Center, Natori, Japan
6Department of Geriatric Medicine and Nephrology, Graduate School of Medicine, Osaka University, Osaka, Japan
7Division of Nephrology, Hypertension and Endocrinology, Department of Medicine, Nihon University Itabashi Hospital, Tokyo, Japan
8Department of Endocrinology and Metabolism, Tokyo Women's Medical University, Tokyo, Japan
9Department of Endocrinology and Metabolism, School of Medicine, Hirosaki University, Hirosaki, Japan
10Division of Nephrology, Endocrinology and Vascular Medicine, Department of Medicine, School of Medicine, Tohoku University, Sendai, Japan
11Council Member Examination Committee of Social Insurance, Ministry of Health, Labour and Welfare, Tokyo, Japan
12Department of Endocrinology, Metabolism, and Hypertension, National Hospital Organization, Kyoto Medical Center, Kyoto, Japan
- Correspondence should be addressed to N Kimura; Email: kimura-path{at}hnh.hosp.go.jp
- © 2014 Society for Endocrinology